top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us
.

Medicines Management in the East Lancashire Health Economy

Information on this website has been provided by the East Lancashire Medicines Management Board which oversees Medicines Management issues across the East Lancashire Health Economy (population 522,000), which consists of;

 

 

The Medicines Management Board (MMB)  consists of physicians and representatives of other key decision-makers in the use of medicines in primary and secondary care. The remit of this board is to review selected pharmaceutical products to assess their clinical value, safety and suitability for use in the East Lancashire Health Economy, and to guide all prescribers in primary and secondary care in using them appropriately.

 

Typical drugs that are considered include newly licensed drugs or those that have a new indication and drugs used to treat conditions with which primary care prescribers may be less familiar. Unlicensed drugs and individual requests are also considered. Requests for drugs to be reviewed may be made by any health care professional in the East Lancashire Health Economy.

The recommendations of the MMB and the evidence considered in the evaluations are summarised in the New Drug Reviews. When use with a shared care agreement is recommended for a particular drug an effective Shared Care Agreement is provided for local use. These documents are available on the website under " New Drug Reviews ” and “ Shared Care Protocols ” respectively.  

 

Any decisions on drug use are also included into the Joint Medicines Formulary, which acts as a

reference to medicines approved for use in East Lancashire.  The Joint Medicines Formulary is formatted in the same style of the BNF, and provides all prescribers with a defined list of medicines that are available to prescribe, as well as the traffic light recommendation for each and any other recommendations for their use.  The Joint Medicines Formulary is available on the website under the “ Medicines Formulary ” heading above. Within East Lancashire a Joint Wound Care Formulary has also been developed, which forms the basis for the prescribing of cost effective and evaluated wound care products, as well as giving guidance on selection of dressing, specialist products, and available sizes.  It is available on the website under the " Wound Care Formulary " heading above.

 

The MMB also provides supporting information on some general prescribing issues (e.g. product withdrawals) as well as ratifying prescribing and clinical guidelines, treatment protocols and integrated care pathways for use across East Lancashire, all of which can be found above under  "Guidelines ".

 

Latest decisions of the MMB are listed on the MMB website update email that is sent out each month.  Health care professionals in East Lancashire can also register to receive this and other news by clicking on the link at the top of the page.  Planned activities and other relevant news items can be found in our monthly newsletter  INTERFACE that is distributed to all healthcare professionals across East Lancashire and is also available online under the heading “ Newsletters & Minutes ” on the left hand navigation panel.

 

For Freedom of Information Requests, please contact:

foi@bwd.nhs.uk – NHS Blackburn with Darwen

foi@eastlancspct.nhs.uk – NHS East Lancashire

 

 

Latest Updates by Section

INTERFACE - Latest Edition

NICE Bites - Latest Edition

 

MHRA Drug Safety Update -

Latest Edition 

 

Newsletters and Minutes

 

30th April 2012

 

Medicines Management Board Minutes March 2012



 

Newsletters

 

27th April 2012

 

Latest Edition of Interface


NICE Guidance App for Mobiles

 

25th April 2012

 

Nice has developed a mobile app to allow users to access guidance from their smart phone - CLICK HERE 


Non Clinical Guidlines & Policies

 

25th April 2012

 

Managing Medicines  on Transfer of Care - overarching policy 



 Non Medical Prescribers

 

24th April 2012

 

Changes to Controlled Drug Legislation for nurse and pharmacist independent prescribers


 MHRA Class 4 Drug Alert:

 

24th April 2012

 

Epistatus, Midazolam 10mg in 1ml Buccal Liquid - Update


HPA letter to GPs regarding increase in pertussis activity

 

24th April 2012

 

Link to letter



Non Medical Prescribing Forum

 

24th April 2012

 

NMP Forum Minutes April 2012


Exenatide/Liraglutide New Patient Treatment Agreement Form

 

20th April 2012

 

Exenatide/Liraglutide New Patient Treatment Agreement Form


Exenatide/Liraglutide Review Treatement Agreement Form

 

20th April 2012

 

Exenatide/Liraglutide Review Treatement Agreement Form


PbR Excluded Drugs Status for ELHE 2012/13 - March 2012 update

 

19th April 2012

 

PbR Excluded Drugs Status for ELHE 2012/13

 


Guidelines for the Pharmacological Management of Non-Cancer  Pain in Adults

 

19th April 2012

 

Pharmacological Management of Non-Cancer  Pain in Adults


HbA1c Conversion table

 

17th April 2012

 

Link to Conversion Table


NICE Bites latest edition

 

17th April 2012

 

NICE Bites April 2012 


Shared Care Guidleine for Atypical Antipsychotics

 

17th April 2012

 

Atypical Antipsychotic Shared Care Guidleine

 


Accredited EHC Pharmacies in East Lancashire and Blackburn with Darwen

 

30th March 2012

 

Accredited EHC Pharmacies March 2012


 NICE Bites latest edition

 

30th March 2012

 

NICE Bites March 2012



Medicine Specific Guideline

 

23rd March 2012

 

Rituximab (MabThera) in rheumatoid arthritis non-NICE approved indications policy


MHRA Class 1 Drug Alert

 

23rd March 2012

 

Wockhardt UK Ltd - Co-codamol 8/500mg tablets containing rogue Co-codamol 30/500mg tablets


New Drug Review

 

22nd March 2012

 

Rituximab (MabThera®) for treatment of ANCA Positive Vasculitis



East Lancashire Health Economy Ticagrelor Poisiton Statement

 

22nd March 2012

 

ELHE Position Statement -Ticagrelor for treatment of acute coronary syndromes 


Latest Edition of Interface

 

20th March 2012

 

Interface February 2012


Advice to GPs about the use of oxycodone for post-operative pain

 

16th March 2012

 

Oxycodone use for post-operative pain - GP Advice


Patient Information about  Post-operative pain

 

16th March 2012

 

Post-operative pain relief - Patient Information


MHRA Opioids Learning Module

 

15th March 2012

 

CLICK HERE to link to Learning Module


 

Letter re withdrawl of Meningococcal Polysaccharide (ACWY) PGD

 

14th March 2012

 

Meningococcal Polysaccharide (ACWY) vaccine PGD withdrawl letter


MHRA Class 4 Drug Alert

 

8th March 2012

 

Epistatus, Midazolam 10mg in 1ml Buccal Liquid x 5ml-Caution in Use -ADDITIONAL INFORMATION


Food First Guidelines - sip feed request form

 

5th March 2012

 

Sip Food Request Form


MHRA - Class 4 Drug Alert: Aurum Pharmaceuticals Ltd (t/a Martindale Pharma) - Adrenaline 1:1000 for Anaphylaxis  PFS & Atropine Sulphate 600mcg in 1ml PFS 

 

5th March 2012

 

Link to MHRA section/document


Medicines Management Board Minutes

 

29th February 2012

 

MMB Minutes January 2012


MHRA Suspends Licence for TEVA Levothyroxine 100 microgram

 

29th February 2012

 

Link to MHRA press release and Q&A document


MHRA Class 4 Drug Alert

 

29th February 2012

 

Epistatus, Midazolam 10mg in 1ml Buccal Liquid x 5ml


East Lancashire Health Economy

Ozurdex Position Statement

 

28th February 2012

 

Ozurdex Position Statement  ELHE


23rd February 2012

 

New Drug Review

 

Duloxetine - for Diabetic Neuropathic Pain


16th February 2012

 

MHRA Drug Alert

 

Class 4 Drug Alert - Clexane 40mg/0.4ml Syringe (Sanofi-aventis


 

13th February 2012

 

Medicines Specific Guidelines

 

Antibiotic Guidelines for Primary Care - Final Version


Guidelines - Disease and Condition Specific

 

Management Guidelines for Diabetic Foot Ulcer, Wound, lesion, Infection


10th February 2012

 

Newsletter and Minutes

 

Nice Bites Issue 38 - Epilepsy



 

MHRA

 

February Drug Safety Update 


MHRA Drug Alert

 

Class 3 Drug Alert - teva UK Ltd -Alendronic Acid  10mg tablets


Patient Group Directions

 

3rd February 2012

 

Combined Hepatitis A & B Vaccine

 

PCV (Prevanar 13) PGD

 

Adrenalin 1 -1000 i/m injection for treatment of Anaphylactic Reaction

_________________________

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.

Email: Interface@bwd.nhs.uk

Powered by EasySite™ Content Management System